Mandeg, Rachel S.

HRN: 03-33-01  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/07/2025
CEFTRIAXONE 1G (VIAL)
02/07/2025
02/14/2025
IV
2g
OD
Complicated Uti
Waiting Final Action 
02/07/2025
MUPIROCIN 2%, 15G (TUBE)
02/07/2025
02/14/2025
TOPICAL
15g
Bid
Decubitus Ulcer
Waiting Final Action 
02/08/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
02/08/2025
02/15/2025
IV
600mg
Q8
Decubitus Ulcer
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: